FindTrial
Sign In

Using Sub Arachanoid Block with Bupivacaine Heavy 0.25 percent for urological procedures.

Hyperbaric spinal Anaesthesia with Bupivacaine 0.25 percent for urological procedures. - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074906
Enrollment
60
Registered
2024-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N289- Disorder of kidney and ureter, unspecified

Interventions

Intervention1: HYPERBARIC BUPIVACAINE 0.25 %: Hyperbaric spinal Anaesthesia with Bupivacaine 0.25 % for urological procedures Dose: 1ml Frequency: single shot Route of Administration: Intra thecal Du

Sponsors

GSVM
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with American society of anaestheslogist (ASA) score: I and II 2) Elective urological endoscopic surgery. 3) Duration of surgery not exceeding 45 min

Exclusion criteria

Exclusion criteria: 1) Negative consent 2) Patients with ASA score III, IV 3) Body mass index (BMI) > 30 kg/m2 4) History of obstructive sleep apnoea 5) Anticipated difficult intubation 6) Spine deformities, previous spine surgery 7) Coagulation abnormalities 8) Allergy to local anaesthetics

Design outcomes

Primary

MeasureTime frame
Effective sensory block ( onset and duration) Effective motor block ( onset and duration) Hemodynamic stability Timepoint: Base line, 4 weeks, 8 weeks.—

Secondary

MeasureTime frame
Adverse effectsTimepoint: Base line, 4 weeks, 8 weeks.—

Countries

India

Contacts

Public ContactNEHA KUMAR

GSVM MEDICAL COLLEGE, KANPUR

dr.nehamishra86@gmail.com08874311115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026